Spielberger CD, Reheiser EC, Sydeman SJ. Measuring the experience, expression, and control of anger. Issues Compr Pediatr Nurs. 1995;18(3):207–32. https://doi.org/10.3109/01460869509087271.

Article  CAS  PubMed  Google Scholar 

Starner TM, Peters RM. Anger expression and blood pressure in adolescents. J Sch Nurs. 2004;20(6):335–42. https://doi.org/10.3109/01460869509087271.

Article  PubMed  Google Scholar 

Chen B, Detyniecki K, Choi H, et al. Psychiatric and behavioral side effects of anti-epileptic drugs in adolescents and children with epilepsy. Eur J Paediatr Neurol. 2017;21:441–9. https://doi.org/10.1016/j.ejpn.2017.02.003.

Article  CAS  PubMed  Google Scholar 

Ettinger AB. Psychotropic effects of antiepileptic drugs. Neurology. 2006;67:1916–25. https://doi.org/10.1212/01.wnl.0000247045.85646.c0.

Article  CAS  PubMed  Google Scholar 

Stephen LJ, Wishart A, Brodie MJ. Psychiatric side effects and antiepileptic drugs: observations from prospective audits. Epilepsy Behav. 2017;71:73–8. https://doi.org/10.1016/j.yebeh.2017.04.003.

Article  PubMed  Google Scholar 

Strzelczyk A, Schubert-Bast S. Psychobehavioural and cognitive adverse events of anti-seizure medications for the treatment of developmental and epileptic encephalopathies. CNS Drugs. 2022;36(10):1079–111. https://doi.org/10.1007/s40263-022-00955-9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Welton JM, Walker C, Riney K, et al. Quality of life and its association with comorbidities and adverse events from antiepileptic medications: online survey of patients with epilepsy in Australia. Epilepsy Behav. 2020;104: 106856. https://doi.org/10.1016/j.yebeh.2019.106856.

Article  PubMed  Google Scholar 

de Kinderen RJ, Evers SM, Rinkens R, et al. Side-efects of antiepileptic drugs: the economic burden. Seizure. 2014;23(3):184–90. https://doi.org/10.1016/j.seizure.2013.11.009.

Article  PubMed  Google Scholar 

American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington: American Psychiatric Association Publishing; 2013.

Book  Google Scholar 

Connor DF, Glatt SJ, Lopez ID, et al. Psychopharmacology and aggression. I: a meta-analysis of stimulant effects on overt/covert aggression-related behaviors in ADHD. J Am Acad Child Adolesc Psychiatry. 2002;41:253–61. https://doi.org/10.1097/00004583-200203000-00004.

Article  PubMed  Google Scholar 

Stringaris A, Cohen P, Pine DS, et al. Adult outcomes of youth irritability: a 20-year prospective community-based study. Am J Psychiatry. 2009;166(9):1048–54. https://doi.org/10.1176/appi.ajp.2009.08121849.

Article  PubMed  PubMed Central  Google Scholar 

Mula M, Cock HR. More than seizures: improving the lives of people with refractory epilepsy. Eur J Neurol. 2015;22(1):24–30. https://doi.org/10.1111/ene.12603.

Article  CAS  PubMed  Google Scholar 

Scheffer IE, Berkovic S, Capovilla G, et al. ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017;58(4):512–21. https://doi.org/10.1111/epi.13709.

Article  PubMed  PubMed Central  Google Scholar 

Ünal F, Öktem F, Çetin Çuhadaroğlu F, et al. Reliability and validity of the schedule for affective disorders and schizophrenia for school-age children-present and lifetime version, DSM-5 November 2016-Turkish adaptation (K-SADS-PL-DSM-5-T). Turk J Psychiatry. 2019. https://doi.org/10.5080/u23408.

Article  Google Scholar 

Spielberger CD. State‐Trait anger expression inventory. The Corsini encyclopedia of psychology. 2010, pp. 1–1. https://doi.org/10.1002/9780470479216.corpsy0942.

Özer AK. Sürekli öfke (SL-Öfke) ve öfke ifade tarzı (Öfke-tarz) ölçekleri ön çalışması. Türk Psikoloji Dergisi. 1994;9:26–35.

Google Scholar 

Turgay A. Disruptive behavior disorders child and adolescent screening and rating scales for children, adolescents, parents and teachers. West Bloomfield: Integrative Therapy Institute Publication; 1994.

Ercan ES, Amado S, Somer O, Çıkoğlu S. Dikkat eksikliği hiperaktivite bozukluğu ve yıkıcı davranım bozuklukları için bir test bataryası geliştirme çabası. Çocuk Gençlik Ruh Sağlığı Derg. 2001;8:132–44.

Google Scholar 

Dureau-Pournin C, Pédespan JM, Droz-Perroteau C, et al. Continuation rates of levetiracetam in children from the EULEVp cohort study. Eur J Paediatr Neurol. 2014;18(1):19–24. https://doi.org/10.1016/j.ejpn.2013.07.003.

Article  PubMed  Google Scholar 

Feng XF, Chen YX, Liu L, et al. Retention rates of levetiraceram in Chinese children and adolescents with epilepsy. Eur J Paediatr Neurol. 2015;19(2):143–8. https://doi.org/10.1016/j.ejpn.2014.11.001.

Article  PubMed  Google Scholar 

Zaccara G, Giovannelli F, Giorgi FS, et al. Tolerability of new antiepileptic drugs: a network meta-analysis. Eur J Clin Pharmacol. 2017;73(7):811–7. https://doi.org/10.1007/s00228-017-2245-z.

Article  CAS  PubMed  Google Scholar 

Lagae L, Buyse G, Ceulemans B. Clinical experience with levetiracetam in childhood epilepsy: an add-on and mono-therapy trial. Seizure. 2005;14(1):66–71. https://doi.org/10.1016/j.seizure.2004.10.004.

Article  CAS  PubMed  Google Scholar 

Callenbach PM, Arts WF, Ten HR, et al. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study. Eur J Paediatr Neurol. 2008;12(4):321–7. https://doi.org/10.1016/j.ejpn.2007.09.004.

Article  PubMed  Google Scholar 

Grosso S, Franzoni E, Coppola G, et al. Efficacy and safety of levetiracetam: an add-on trial in children with refractory epilepsy. Seizure. 2005;14(4):248–53. https://doi.org/10.1016/j.seizure.2005.02.004.

Article  CAS  PubMed  Google Scholar 

Peake D, Mordekar S, Gosalakkal J, et al. Retention rate of levetiracetam in children with intractable epilepsy at 1 year. Seizure. 2007;16(2):185–9. https://doi.org/10.1016/j.seizure.2006.12.001.

Article  CAS  PubMed  Google Scholar 

de la Loge C, Hunter SJ, Schiemann J, et al. Assessment of behavioral and emotional functioning using standardized instruments in children and adolescents with partial-onset seizures treated with adjunctive levetiracetam in a randomized, placebo-controlled trial. Epilepsy Behav. 2010;18(3):291–8. https://doi.org/10.1016/j.yebeh.2010.04.017.

Article  PubMed  Google Scholar 

Matsuo M, Fuji A, Matsuzaka T, et al. Effectiveness and safety of long-term levetiracetam treatment in patients with refractory epilepsy. No To Hattatsu. 2015;47:272–8.

PubMed  Google Scholar 

Depakene (valproic acid). Prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/01808.1s065_018082s048lbl.pdf. Accessed 29 Aug 2022.

Epilim (sodium valproate). Summary of product characteristics. https://www.medicines.org.uk/emc/product/1446/smpc#gref. Accessed 29 Aug 2022.

Stahl SM. Anticonvulsants as mood stabilizers and adjuncts to antipsychotics: valproate, lamotrigine, carbamazepine, and oxcarbazepine and actions at voltage gated sodium channels. J Clin Psychiatry. 2004;65:738–9.

Article  PubMed  Google Scholar 

Chen B, Choi H, Hirsch LJ, et al. Psychiatric and behavioral side efects of antiepileptic drugs in adults with epilepsy. Epilepsy Behav. 2017;76:24–31. https://doi.org/10.1016/j.yebeh.2017.08.039.

Article  PubMed  Google Scholar 

Realmuto S, Zummo L, Cerami C, et al. Social cognition dysfunctions in patients with epilepsy: evidence from patients with temporal lobe and idiopathic generalized epilepsies. Epilepsy Behav. 2015;47:98–103. https://doi.org/10.1016/j.yebeh.2015.04.048.

Article  PubMed  Google Scholar 

Koo DL, Hwang KJ, Kim D, et al. Effects of levetiracetam monotherapy on the cognitive function of epilepsy patients. Eur Neurol. 2013;70(1–2):88–94. https://doi.org/10.1159/000347230.

Article  CAS  PubMed  Google Scholar 

Stephen LJ, Kelly K, Parker P, et al. Levetiracetam monotherapy—outcomes from an epilepsy clinic. Seizure. 2011;20(7):554–7. https://doi.org/10.1016/j.seizure.2011.04.004.

Article  PubMed  Google Scholar 

Lopez-Gongora M, Martinez-Domerio A, Garcia C, et al. Effect of levetiracetam on cognitive functions and quality of life: a one-year follow-up study. Epileptic Disord. 2008;10(4):297–305.